Always stay up to date and never miss a thing.

The most exciting news from PELOBiotech and Partners.

pelobiotech-gmbh-gmp-quality-9705.jpg

How the right tools from PELOBiotech can boost Stem Cell research today

10. November 2021

New formulation of truly chemically defined media

Induced pluripotent stem cells, or iPS cells for short, are created in the lab but resemble the stem cells of an embryo. Biologists use them to study diseases, doctors for the development of new therapies with the help of patient-specific drug testing.

PELOBiotech meets BIO-Europe 2021 - 1.png

Meet us at... Bio Europe 2021

18. October 2021

We will be at the Bio Europe digital meeting from 25-28 October.

Take the opportunity to meet with us for a presentation of our services and models. Dr. Peter Frost (Peter.frost@pelobiotech.com) will be happy to discuss further with you how we could be of assistance for your industrial and clinical project.

iPS.jpg

The ultimate Overview of PELOBiotech’s popular Stem Cell &  ES/iPS cell products of 2021

04. October 2021

Stem cells ES/iPS cells and derived products offer great promise for new medical treatments and wide research fields. For this, PELOBiotech had a long look at its portfolio with over 500 relevant ES/iPS and Stem cell products. Get now the big picture of this advanced research field with your Stem Cell experts at your side.

And if you like to know more about our ES/iPS and Stem cell portfolio you can meet our CSO&CEO Dr. Lothar Steeb at the GSCN - live and in person - this week, Oct 06-08, in Dresden.

High Grade products, Stem Cells for highest demands.

pelobiotech-gmbh-happy-researcher-lab-9841.jpg

PELONEWS: New Cooperation with Hochschule Reutlingen – How Obesity can impact Lung Diseases and COVI

06. July 2021

The first Development of a Lung Adipose Tissue Model and corresponding defined medium by PELOBiotech Cell culture specialist PELOBiotech GmbH is collaborating with Hochschule Reutlingen

pelobiotech-gmbh-logo-news.svg

Meet us at … Cardiovascular Disease Symposium.

04. May 2021

We are happy to support the Cardiovascular Disease Symposium “CaVaD”, an event organized by doctoral researchers from the Heinrich Heine University Düsseldorf. The PhD-Meeting aims to provide a platform …

pelobiotech-gmbh-mymatrix_ips_cells.jpg

PELONews: myMATRIX iPSC: Xeno-free & Chemically Defined iPSC Culture.

27. April 2021

Ever wondered what an animal-source free Extracellular Matrix (ECM) could do to your Pluripotent Stem Cells (PSC)?

pelobiotech-gmbh-3d-technology-vivtro.jpg

PELONews: PELOBiotech is New Partner for Innovative 3D Cell Culture Technology VITVO®

29. March 2021

PELOBiotech GmbH is proud to announce that with Rigenerand SRL, Italy, we were able to sign up a very innovative partner in the field of 3D Cell Culture models. PELOBiotech will exclusively distribute …

pelobiotech-gmbh-pancreas-iStock-508173087.jpg

PELOAcademy: Challenges of Recovering Islets from Chronic Pancreatitis Patients.

11. February 2021

Islet yield is the critical factor for the success of autologous islet transplantation. The higher the islet yield, the higher probability of the recipient will have an easier time managing iatrogenic …